Steven Deitelzweig
Overview
Explore the profile of Steven Deitelzweig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
474
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Deitelzweig S, Bergrath E, Di Fusco M, Kang A, Savone M, Cappelleri J, et al.
Future Cardiol
. 2022 Apr;
18(5):393-405.
PMID: 35360925
To compare real-world effectiveness/safety of non-vitamin K antagonist oral anticoagulants and vitamin K antagonists among patients with non-valvular atrial fibrillation. A systematic review of electronic databases yielded 7661 citations published...
12.
Deitelzweig S, Keshishian A, Zhang Y, Kang A, Dhamane A, Luo X, et al.
JACC CardioOncol
. 2021 Oct;
3(3):411-424.
PMID: 34604802
Background: Patients with cancer are more likely to develop nonvalvular atrial fibrillation (NVAF). Currently there are no definitive clinical trials or treatment guidelines for NVAF patients with concurrent cancer. Objectives:...
13.
Peacock W, Levy P, Diercks D, Li S, Wang T, McCord J, et al.
Crit Pathw Cardiol
. 2021 Sep;
20(4):173-178.
PMID: 34494982
Background: Whether American College of Cardiology (ACC) Chest Pain Center (CPC) accreditation alters guidelines adherence rates is unclear. Methods: We analyzed patient-level, hospital-reported, quality metrics for myocardial infarction (MI) patients...
14.
Lip G, Keshishian A, Zhang Y, Kang A, Dhamane A, Luo X, et al.
JAMA Netw Open
. 2021 Aug;
4(8):e2120064.
PMID: 34398204
Importance: Many patients with nonvalvular atrial fibrillation (NVAF) are at a high risk of gastrointestinal (GI) bleeding due to conditions including older age; stage III to V chronic kidney disease...
15.
Deitelzweig S, Keshishian A, Kang A, Dhamane A, Luo X, Klem C, et al.
Adv Ther
. 2021 May;
38(6):3166-3184.
PMID: 33963511
Introduction: Non-valvular atrial fibrillation (NVAF) is often accompanied by multiple comorbid conditions, which increase the associated risks and complexity of patient management. This study evaluated the risk of stroke/systemic embolism...
16.
Deitelzweig S, Keshishian A, Kang A, Dhamane A, Luo X, Balachander N, et al.
Therap Adv Gastroenterol
. 2021 Apr;
14:1756284821997352.
PMID: 33815568
Background: Gastrointestinal (GI) bleeding is the most common type of major bleeding associated with oral anticoagulant (OAC) treatment. Patients with major bleeding are at an increased risk of a stroke...
17.
Deitelzweig S, Di Fusco M, Kang A, Savone M, Mokgokong R, Keshishian A, et al.
Curr Med Res Opin
. 2021 Mar;
37(6):891-902.
PMID: 33686900
Objective: To conduct a systematic review and network meta-analysis of real-world evidence comparing adherence, persistence, cost, and utilization between oral anticoagulant (OAC) in non-valvular atrial fibrillation (NVAF) patients. Methods: A...
18.
Hill J, Garcia D, Crowther M, Savage B, Peress S, Chang K, et al.
Blood Adv
. 2020 Nov;
4(21):5373-5377.
PMID: 33137202
Patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appear to be at increased risk for venous thromboembolism (VTE), especially if they become critically ill with COVID-19. Some centers...
19.
Deitelzweig S, Dhamane A, Di Fusco M, Russ C, Rosenblatt L, Lingohr-Smith M, et al.
J Med Econ
. 2020 Oct;
23(12):1389-1400.
PMID: 33021129
Objective: To evaluate utilization of anticoagulants (ACs) and the predictors of treatment of patients with a diagnosis of atrial fibrillation (AF) during a hospital stay in the USA. Methods: Patients...
20.
Lip G, Keshishian A, Kang A, Dhamane A, Luo X, Klem C, et al.
Eur Heart J Cardiovasc Pharmacother
. 2020 Oct;
7(5):405-414.
PMID: 33010157
Aims: Polypharmacy is prevalent among non-valvular atrial fibrillation (NVAF) patients and presents a potential issue for the effective management of NVAF. This study compared the risk of stroke/systemic embolism (SE)...